DAVID SNYDER

Profile

First Name

: DAVID

Middle Name

:

Last Name

: SNYDER

Related Companies
Titles
Company Name
Related People
DIRECTOR
VICTORY PHARMA INC
SCOTT BARRY, MATTHEW HECK, HERBERT HOOPER, JAMES NEWMAN, DAVID PARKER, DANIEL STOKELY, THOMAS WIGGANS
EXECUTIVE OFFICER, DIRECTOR
SUMMIT CRA MULTI-FAMILY HOUSING FUND II LLC
KERRY W BOEKELHEIDE, STEVE KIRBY
EXECUTIVE OFFICER
CELLULAR DYNAMICS INTERNATIONAL, INC.
MICHAEL FALK, MICHAEL E. FALK, KENNETH C. HUNT, CRAIG JANUARY, CRAIG T. JANUARY, CHRISTOPHER KENDRICK-PARKER, LEONARD T. LOVENTHAL, GREGORY LYNCH, GREGORY J. LYNCH, EMILE NUWAYSIR, EMILE F. NUWAYSIR, ROBERT J. PALAY, THOMAS M. PALAY, CHRISTOPHER PARKER, CHRISTOPHER J. PARKER, STANLEY ROSE, STANLEY D. ROSE, SHELI Z. ROSENBERG, NICHOLAS SEAY, NICHOLAS J. SEAY, DAVID S. SNYDER, JAMES A. THOMSON, MICHAEL J. VAN HANDEL
EXECUTIVE OFFICER
NEUROVISTA CORP
MIKE CARUSI, DAVID DOUGLASS, ANDREW FIRLIK, STEVEN GOURLAY, JOHN F. HARRIS, KENT LEYDE, HUGH MATSUBAYASHI, W. DOUGLAS SHEFFIELD, JAY WARREN
DIRECTOR
INVENRA INC.
ROLAND GREEN, RICHARD LESNIEWSKI, EMILE NUWAYSIR, STAN ROSE, PAUL WEISS
EXECUTIVE OFFICER
RENAISSANCE APARTMENT OPPORTUNITY FUND, LLC
MARK FIGHTMASTER, JACK KERN, JASON ROSA, DON SILVERSMITH, TYLER STOWATER
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS BELLEVUE TECHNOLOGY CENTER, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS WEST LOOP I + II, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS US PROPERTIES REIT, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS 1800 WEST LOOP, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS MAITLAND PROMENADE, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS NORTHRIDGE CENTER, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS WESTMOOR CENTER, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS US PARENT REIT, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS PLAZA BUILDINGS, INC.
ANDY GWEE, AI LIN SEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS POWERS FERRY LANDING, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS IRON POINT, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS GREAT HILLS PLAZA, INC.
ANDY GEWEE, ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KEPPEL-KBS WESTECH 360, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KORE NORTHRIDGE CENTER, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KORE POWERS FERRY LANDING, INC.
ANDY GWEE
DIRECTOR
GO4ELLIS, INC.
ANDREW HAYES, ANDY KAPLAN
EXECUTIVE OFFICER, DIRECTOR
KORE 1800 WEST LOOP, INC.
ANDY GWEE
EXECUTIVE OFFICER
COYA THERAPEUTICS, INC.
HOWARD BERMAN, HIDEKI GARREN, ANDREA GOLDSTEIN, DOV GOLDSTEIN, FRED GROSSMAN, ADRIAN HEPNER, ANN LEE, GREG MACMICHAEL, WILBUR ROSS, ARUN SWAMINATHAN, SHAWN M. TITCOMB, JANI TUOMI, ANABELLA VILLALOBOS, DIETER WEINAND
EXECUTIVE OFFICER, DIRECTOR
KORE BELLEVUE TECHNOLOGY CENTER, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KORE WEST LOOP I + II, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KORE MAITLAND PROMENADE, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KORE WESTMOOR CENTER, INC.
ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KORE GREAT HILLS PLAZA, INC.
ANDY GEWEE, ANDY GWEE
EXECUTIVE OFFICER, DIRECTOR
KORE WESTECH 360, INC.
ANDY GWEE
EXECUTIVE OFFICER
KORE 105 EDGEVIEW, LLC
AI LIN SEE
EXECUTIVE OFFICER
KORE 125 JOHN CARPENTER, LLC
AI LIN SEE
EXECUTIVE OFFICER
KORE MAITLAND PROMENADE I, LLC
AI LIN SEE
EXECUTIVE OFFICER
KORE WESTPARK, LLC
AI LIN SEE
EXECUTIVE OFFICER, DIRECTOR
KORE PLAZA BUILDINGS, INC.
ANDY GWEE, AI LIN SEE
EXECUTIVE OFFICER
KORE BRIDGE CROSSING, LLC
AI LIN SEE
DIRECTOR
BTB THERAPEUTICS, INC.
MASATOSHI HAGIWARA, TAKASHI KIYOIZUMI, NOBUHIRO YAGI
EXECUTIVE OFFICER
TC CYPRESS LP
BRADY JEWETT, KRISTOPHER OSTRANDER, - TORREYANA CAPITAL, LLC, - TORREYANA UGP LLC, TALIN WAUCHOPE
EXECUTIVE OFFICER
ONE TEAM INSURANCE LLC
N/A CUSTOMER FIRST INSURANCE AGENCY LLC, SEAN FRIEDLAND, GAURAV GAMBHIR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2026-01-01 
2025-12-10
D
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2025-09-25 
2025-12-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-11-14 
2025-08-25
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-31 
2025-08-25
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-31 
2025-08-18
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-31 
2025-08-18
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-31 
2025-08-18
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-31 
2025-08-18
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-31 
2024-10-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-10-23 
2023-12-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-05 
2022-12-23
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
2022-12-23
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
2022-12-23
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
2022-12-23
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
2022-12-23
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
2022-12-23
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
2022-05-26
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-26 
2022-05-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-04-05 
2022-03-21
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-15 
2021-02-05
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-28 
2021-02-05
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-28 
2018-10-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-01 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-15
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-11-14
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-31 
2017-10-05
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2017-09-20 
2016-07-20
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2016-07-12 
2015-08-25
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2015-08-13 
2015-08-11
D/A
Link
RESIDENTIAL 
 
NO REVENUES 
Equity 
2014-07-29 
2015-05-26
D/A
Link
RESIDENTIAL 
 
NO REVENUES 
Equity 
2014-07-29 
2015-04-20
D/A
Link
RESIDENTIAL 
 
NO REVENUES 
Equity 
2014-07-29 
2015-03-05
D
Link
RESIDENTIAL 
 
NO REVENUES 
Equity 
2014-07-29 
2015-01-28
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2015-01-14 
2013-02-20
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2013-02-08 
2012-11-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-01 
2011-04-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-05 
2010-08-24
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-08-18 
2010-08-24
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-18 
2010-02-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-21 
2010-01-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-21 
2009-05-07
D/A
Link
RESIDENTIAL 
 
$5,000,001 - $25,000,000 
Equity, Debt 
2008-08-29 
2009-03-23
D
Link
PHARMACEUTICALS 
 
$25,000,001 - $100,000,000 
Equity 
2009-03-02